| Product Code: ETC12973730 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Narcolepsy Drugs Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Narcolepsy Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Narcolepsy Drugs Market - Industry Life Cycle |
3.4 Poland Narcolepsy Drugs Market - Porter's Five Forces |
3.5 Poland Narcolepsy Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Poland Narcolepsy Drugs Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.7 Poland Narcolepsy Drugs Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 Poland Narcolepsy Drugs Market Revenues & Volume Share, By Patient Group, 2021 & 2031F |
3.9 Poland Narcolepsy Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Poland Narcolepsy Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of narcolepsy in Poland |
4.2.2 Growing demand for effective narcolepsy treatment options |
4.2.3 Advancements in pharmaceutical research leading to the development of innovative drugs for narcolepsy |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare services for narcolepsy diagnosis and treatment in Poland |
4.3.2 High cost of narcolepsy drugs leading to affordability issues for patients |
4.3.3 Lack of reimbursement policies for narcolepsy drugs by healthcare insurance providers in Poland |
5 Poland Narcolepsy Drugs Market Trends |
6 Poland Narcolepsy Drugs Market, By Types |
6.1 Poland Narcolepsy Drugs Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Poland Narcolepsy Drugs Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Poland Narcolepsy Drugs Market Revenues & Volume, By Stimulants, 2021 - 2031F |
6.1.4 Poland Narcolepsy Drugs Market Revenues & Volume, By Wakefulness-Promoting Agents, 2021 - 2031F |
6.1.5 Poland Narcolepsy Drugs Market Revenues & Volume, By Antidepressants, 2021 - 2031F |
6.1.6 Poland Narcolepsy Drugs Market Revenues & Volume, By Sodium Oxybate, 2021 - 2031F |
6.1.7 Poland Narcolepsy Drugs Market Revenues & Volume, By Histamine H3 Receptor Antagonists, 2021 - 2031F |
6.2 Poland Narcolepsy Drugs Market, By Form |
6.2.1 Overview and Analysis |
6.2.2 Poland Narcolepsy Drugs Market Revenues & Volume, By Tablet, 2021 - 2031F |
6.2.3 Poland Narcolepsy Drugs Market Revenues & Volume, By Capsule, 2021 - 2031F |
6.2.4 Poland Narcolepsy Drugs Market Revenues & Volume, By Liquid, 2021 - 2031F |
6.2.5 Poland Narcolepsy Drugs Market Revenues & Volume, By Suspension, 2021 - 2031F |
6.2.6 Poland Narcolepsy Drugs Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 Poland Narcolepsy Drugs Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 Poland Narcolepsy Drugs Market Revenues & Volume, By Dopamine Regulation, 2021 - 2031F |
6.3.3 Poland Narcolepsy Drugs Market Revenues & Volume, By Orexin Activation, 2021 - 2031F |
6.3.4 Poland Narcolepsy Drugs Market Revenues & Volume, By Serotonin Modulation, 2021 - 2031F |
6.3.5 Poland Narcolepsy Drugs Market Revenues & Volume, By GABA Activation, 2021 - 2031F |
6.3.6 Poland Narcolepsy Drugs Market Revenues & Volume, By Histamine Regulation, 2021 - 2031F |
6.4 Poland Narcolepsy Drugs Market, By Patient Group |
6.4.1 Overview and Analysis |
6.4.2 Poland Narcolepsy Drugs Market Revenues & Volume, By Adults, 2021 - 2031F |
6.4.3 Poland Narcolepsy Drugs Market Revenues & Volume, By Teenagers, 2021 - 2031F |
6.4.4 Poland Narcolepsy Drugs Market Revenues & Volume, By Elderly, 2021 - 2031F |
6.4.5 Poland Narcolepsy Drugs Market Revenues & Volume, By Children, 2021 - 2031F |
6.4.6 Poland Narcolepsy Drugs Market Revenues & Volume, By All Ages, 2021 - 2031F |
6.5 Poland Narcolepsy Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Poland Narcolepsy Drugs Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.5.3 Poland Narcolepsy Drugs Market Revenues & Volume, By Online Retail, 2021 - 2031F |
6.5.4 Poland Narcolepsy Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.5.5 Poland Narcolepsy Drugs Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.5.6 Poland Narcolepsy Drugs Market Revenues & Volume, By Prescription Only, 2021 - 2031F |
7 Poland Narcolepsy Drugs Market Import-Export Trade Statistics |
7.1 Poland Narcolepsy Drugs Market Export to Major Countries |
7.2 Poland Narcolepsy Drugs Market Imports from Major Countries |
8 Poland Narcolepsy Drugs Market Key Performance Indicators |
8.1 Average time taken for narcolepsy diagnosis in Poland |
8.2 Number of healthcare facilities offering specialized narcolepsy treatment |
8.3 Patient adherence rate to prescribed narcolepsy drug treatment plan |
9 Poland Narcolepsy Drugs Market - Opportunity Assessment |
9.1 Poland Narcolepsy Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Poland Narcolepsy Drugs Market Opportunity Assessment, By Form, 2021 & 2031F |
9.3 Poland Narcolepsy Drugs Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 Poland Narcolepsy Drugs Market Opportunity Assessment, By Patient Group, 2021 & 2031F |
9.5 Poland Narcolepsy Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Poland Narcolepsy Drugs Market - Competitive Landscape |
10.1 Poland Narcolepsy Drugs Market Revenue Share, By Companies, 2024 |
10.2 Poland Narcolepsy Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here